MUC1 and COVID-19: Moreover, in the majority of patients with fibrotic sequelae, the decrease and substantial normalization of serum KL-6 concentrations may reflect the amelioration of the clinical status, suggesting that fibrotic interstitial lung abnormalities related to COVID-19 are not associated with persistent active epithelial damage and consequent aberrant fibrogenesis.